News & Press: Latest News

MDMA Statement on the Senate Confirmation of Hahn as FDA Commissioner

Thursday, December 12, 2019  
Share |

MDMA Statement on the Senate Confirmation of Hahn as FDA Commissioner


WASHINGTON, DC -- Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding Dr. Stephen Hahn’s confirmation by the Senate to be the next Food and Drug Administration (FDA) Commissioner:


“MDMA congratulates Dr. Hahn for his confirmation as the next FDA Commissioner, and the bipartisan support he received in the Senate is a recognition of his strong track record of advancing patient care and leading large organizations.


MDMA echoes Dr. Hahn's commitment and focus to help ensure that patients have timely access to the cures and therapies being developed by America's innovators, and we look forward to working with him to achieve this important goal.”